Beta Drugs Balance Sheet Health
Financial Health criteria checks 6/6
Beta Drugs has a total shareholder equity of ₹1.6B and total debt of ₹110.0M, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are ₹2.5B and ₹969.8M respectively. Beta Drugs's EBIT is ₹502.2M making its interest coverage ratio 17.8. It has cash and short-term investments of ₹286.3M.
Key information
7.0%
Debt to equity ratio
₹109.98m
Debt
Interest coverage ratio | 17.8x |
Cash | ₹286.33m |
Equity | ₹1.57b |
Total liabilities | ₹969.82m |
Total assets | ₹2.54b |
Recent financial health updates
These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Jul 29Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
Dec 20These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Sep 02Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
May 20Is Beta Drugs (NSE:BETA) A Risky Investment?
Jan 29Recent updates
Earnings Tell The Story For Beta Drugs Limited (NSE:BETA) As Its Stock Soars 29%
Dec 23Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?
Dec 11These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Jul 29Here's Why We Think Beta Drugs (NSE:BETA) Is Well Worth Watching
Jun 17Here's Why I Think Beta Drugs (NSE:BETA) Might Deserve Your Attention Today
Feb 21Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
Dec 20With EPS Growth And More, Beta Drugs (NSE:BETA) Is Interesting
Nov 21These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Sep 02Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
May 20Is Beta Drugs (NSE:BETA) A Risky Investment?
Jan 29Is Beta Drugs Limited's (NSE:BETA) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Dec 25Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)
Nov 20Financial Position Analysis
Short Term Liabilities: BETA's short term assets (₹1.8B) exceed its short term liabilities (₹846.7M).
Long Term Liabilities: BETA's short term assets (₹1.8B) exceed its long term liabilities (₹123.1M).
Debt to Equity History and Analysis
Debt Level: BETA has more cash than its total debt.
Reducing Debt: BETA's debt to equity ratio has reduced from 49.8% to 7% over the past 5 years.
Debt Coverage: BETA's debt is well covered by operating cash flow (281.2%).
Interest Coverage: BETA's interest payments on its debt are well covered by EBIT (17.8x coverage).